Previous research has consistently demonstrated elevated levels of proinflammatory cytokines, including IL-1β, IL-6, and TNF-α, in patients with DN, and anti-inflammatory therapy is one of the important therapeutic approaches for treating DN [33]. This evidence concerns the gene TNF and liver dysplastic nodule.